The Oncology Institute, Inc. (NASDAQ:TOIIW) Short Interest Down 45.2% in December

The Oncology Institute, Inc. (NASDAQ:TOIIW) was the recipient of a large decline in short interest in December. As of December 31st, there was short interest totalling 1,700 shares, a decline of 45.2% from the December 15th total of 3,100 shares. Based on an average daily volume of 24,200 shares, the days-to-cover ratio is currently 0.1 days.

Oncology Institute Trading Down 1.9 %

Shares of Oncology Institute stock opened at $0.02 on Tuesday. The firm has a 50-day simple moving average of $0.01 and a two-hundred day simple moving average of $0.02. Oncology Institute has a fifty-two week low of $0.01 and a fifty-two week high of $0.37.

Oncology Institute Company Profile

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.